Obtaining Intellectual Property Rights For New Medicinal
Obtaining Intellectual Property Rights For New Medicinal Cannabis Varieties - PART 1
In jurisdictions where recreational cannabis use is legal, traditional selective breeding techniques have been used to develop thousands of new cannabis varieties or strains. With the recent enactment of legislation that permits the cultivation of medicinal cannabis in Australia, we are likely to see growth in the commercial development of new cannabis varieties with specific therapeutic traits, as opposed to recreational traits (e.g., euphoria or creativity).
In this first part of a three part series, we highlight the options available for protecting new cannabis plant varieties under Australia's intellectual property regimes.
https://www.facebook.com/queenslandbauxitelimited/?ref=br_rs
Here you have the opportunity to take advantage on facts and info from QBL. Like the ”QBL on ASX” chapter, who can provide verified facts; here is also regulated on-line stockbrokers suggestion, no games info and a good sum up. Voluntary suspension is requested regarding a significant and strategic acquisition by QBL’s subsidiary MEDICAL CANNABIS Limited until Friday 1 of june or before. Contact information to the QBL Investor service, who can reply on questions. https://www.queenslandbauxite.com/
(Australia other timezone)
Robert
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Hims & Hers Revenue Challenges Amid Stock Decline In recent trading sessions, Hims & Hers Health reported notable stock fluctuations as the company unveiled a decline in revenue per customer linked to its customization of GLP-1 medications for weight loss. This announcement caused an almost 11% drop in the stock price. Impacts of Collaboration Termination This steep...
Continue Reading
Entrée Resources Ltd. Overview Entrée Resources Ltd. (TSX: ETG; OTCQB: ERLFF), a reputable Canadian mining company focused on the Oyu Tolgoi project, has announced its interim financial results for the third quarter of 2025. This announcement sheds light on its ongoing operations and future plans, emphasizing the company's significant role in one of the world's largest...
Continue Reading
Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...
Continue Reading
BioLife Solutions Announces $73 Million Sale of SciSafe In a significant move aimed at reinforcing its strategic direction, BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the development and supply of cell processing tools and services for the cell and gene therapy market, has announced the sale of its biostorage subsidiary, SciSafe Holdings, Inc. The...
Continue Reading
Innovative Pathway Towards a Universal COVID-19 Vaccine In the wake of a global resurgence of COVID-19, Dx&Vx (DXVX) is stepping up its efforts to develop a universal vaccine aimed at providing protection against all variants of the virus. With the recent acquisition of cutting-edge technology, this next-generation vaccine is set to attract significant global interest....
Continue Reading